記住我
There is an error in the sixth sentence of the first paragraph of the Introduction which should not include reference to Intellia Therapeutics. The correct sentence is: These promising targeted therapies are the focus of synthetic biology companies such as Locus Biosciences and Eligo Bioscience, to name a few.
1. Palacios Araya D, Palmer KL, Duerkop BA (2021) CRISPR-based antimicrobials to obstruct antibiotic-resistant and pathogenic bacteria. PLoS Pathog 17(7): e1009672. https://doi.org/10.1371/journal.ppat.1009672 pmid:34237097Citation: Araya DP, Palmer KL, Duerkop BA (2021) Correction: CRISPR-based antimicrobials to obstruct antibiotic-resistant and pathogenic bacteria. PLoS Pathog 17(12): e1010153. https://doi.org/10.1371/journal.ppat.1010153
Published: December 13, 2021
Copyright: © 2021 Araya et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
留言 (0)